ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,156Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1456

$1.52M Total Retail Price of All Prescriptions

Rank: 34 out of 1456

984 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 984 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 984 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 22,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 1,378 1,120 1 2
LISINOPRIL 1,111 784 2 3
AMLODIPINE BESYLATE 1,041 794 3 1
MELOXICAM 865 646 4 30
LEVOTHYROXINE SODIUM 768 693 5 4
OMEPRAZOLE 746 637 6 5
METFORMIN HCL 743 506 7 8
FUROSEMIDE 676 568 8 7
SERTRALINE HCL 607 521 9 25
HYDROCODONE-ACETAMINOPHEN 600 499 S3 10 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 586 442 11 24
FLUTICASONE PROPIONATE 515 428 12 28
METOPROLOL TARTRATE 440 290 13 12
ZOLPIDEM TARTRATE 435 367 14 14
METOPROLOL SUCCINATE 393 325 15 19
HYDROCHLOROTHIAZIDE 378 311 16 10
PRAVASTATIN SODIUM 374 257 17 9
GABAPENTIN 370 246 18 13
POTASSIUM CHLORIDE 369 333 19 15
WARFARIN SODIUM 368 320 20 21
RANITIDINE HCL 345 201 21 27
CARVEDILOL 324 218 22 20
ATENOLOL 308 265 23 18
GLIMEPIRIDE 299 246 24 33
CELEBREX 294 237 25 88
LOSARTAN-HYDROCHLOROTHIAZIDE 292 230 26 41
LOSARTAN POTASSIUM 276 228 27 16
NEXIUM 274 161 28 23
LANTUS 262 136 29 50
ATORVASTATIN CALCIUM 262 196 29 11
SINGULAIR 258 200 31 83
CYMBALTA 257 201 32 52
TRAMADOL HCL 255 209 33 17
INSULIN SYRINGE 253 124 34 64
DIOVAN HCT 246 205 35 59
AMITRIPTYLINE HCL 242 184 R 36 70
NAPROXEN 235 192 37 100
ALENDRONATE SODIUM 206 183 38 36
PROPRANOLOL HCL 205 177 39 143
ADVAIR DISKUS 200 139 40 63
HYDRALAZINE HCL 198 117 41 48
SPIRONOLACTONE 195 118 42 73
VENLAFAXINE HCL 186 155 43 215
CLOPIDOGREL 185 131 44 32
TEMAZEPAM 180 163 45 313
DIOVAN 178 159 46 35
TAMSULOSIN HCL 177 145 47 34
LOVASTATIN 164 133 48 40
CRESTOR 162 118 49 26
MONTELUKAST SODIUM 160 122 50 135
AZITHROMYCIN 159 128 51 44
TRIAMTERENE-HCTZ 149 145 52 49
GLIPIZIDE 144 73 53 53
PLAVIX 144 107 53 46
DOXAZOSIN MESYLATE 141 103 55 84
AMLODIPINE BESYLATE-BENAZEPRIL 140 119 56 61
LYRICA 137 84 57 91
POLYETHYLENE GLYCOL 3350 137 120 57 85
ALLOPURINOL 135 84 59 31
ZETIA 135 126 59 71
DONEPEZIL HCL 131 131 61 29
PROAIR HFA 130 45 62 69
KLOR-CON 10 129 111 63 96
ESTRADIOL 125 109 R 64 153
PREDNISONE 121 96 65 42
PAROXETINE HCL 118 116 66 67
KLOR-CON M20 114 78 67 51
DIGOXIN 104 59 68 62
FAMOTIDINE 102 78 69 45
FLUOXETINE HCL 102 68 69 55
SYNTHROID 96 71 71 37
VENLAFAXINE HCL ER 93 80 72 89
CYCLOBENZAPRINE HCL 91 83 R 73 66
SPIRIVA 91 68 73 75
WELCHOL 90 77 75 194
METFORMIN HCL ER 88 76 76 54
CITALOPRAM HBR 84 58 77 22
KLOR-CON M10 81 72 78 140
PROMETHAZINE HCL 80 72 R 79 77
PANTOPRAZOLE SODIUM 80 61 79 43
NAMENDA 79 79 81 38
LIPITOR 79 68 81 76
FELODIPINE ER 72 68 83 150
ACTOS 70 63 84 115
BUPROPION HCL SR 69 63 85 185
JANUMET 69 69 85 176
MECLIZINE HCL 69 66 85 101
BUPROPION XL 67 62 88 165
BENAZEPRIL HCL 67 67 88 57
NABUMETONE 66 64 90 212
JANUVIA 65 55 91 68
GLYBURIDE-METFORMIN HCL 64 54 R 92 119
CIPROFLOXACIN HCL 64 56 92 58
TRIAMCINOLONE ACETONIDE 63 54 94 158
CLONAZEPAM 63 46 94 264
EXFORGE 62 45 96 211
ROPINIROLE HCL 62 37 96 90
DICYCLOMINE HCL 62 43 96 239
DILTIAZEM ER 61 61 99 147
LORAZEPAM 60 58 100 236
ISOSORBIDE MONONITRATE ER 58 39 101 60
METOLAZONE 58 39 101 210
VENTOLIN HFA 57 27 103 121
VESICARE 53 51 104 200
SYMBICORT 53 30 104 157
CLONIDINE HCL 52 26 106 39
TIZANIDINE HCL 52 33 106 116
FENOFIBRATE 51 23 108 56
QUETIAPINE FUMARATE 51 48 108 78
GLIPIZIDE ER 50 42 110 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.